Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001879231-23-000002

EVP, R&D and CMO gave up 2,659 shares (to pay taxes)

  • EVP, R&D and CMO acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Buck Kristen K · EVP, R&D and CMO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-09 Grant or award : show line 1 in the form +18,000 38,482 D
2023-01-09 Shares withheld for taxes : show line 2 in the form −2,147 $3.00 $6,441 36,335 D
2023-01-10 Shares withheld for taxes : show line 3 in the form −512 $3.20 $1,636 35,823 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-09 Grant or award : show line 4 in the form Stock Options (Right to Buy) +9,000 9,000 D
Loading xslF345X03/wf-form4_167347097101144.xml…